Exact Mass: 580.0835

Exact Mass Matches: 580.0835

Found 50 metabolites which its exact mass value is equals to given mass value 580.0835, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Uridine diphosphate glucuronic acid

(2S,3S,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)


Uridine diphosphate glucuronic acid, also known as udpglucuronate or udp-D-glucuronic acid, is a member of the class of compounds known as pyrimidine nucleotide sugars. Pyrimidine nucleotide sugars are pyrimidine nucleotides bound to a saccharide derivative through the terminal phosphate group. Uridine diphosphate glucuronic acid is soluble (in water) and a moderately acidic compound (based on its pKa). Uridine diphosphate glucuronic acid can be synthesized from alpha-D-glucuronic acid. Uridine diphosphate glucuronic acid can also be synthesized into UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronic acid. Uridine diphosphate glucuronic acid can be found in a number of food items such as parsley, chervil, black mulberry, and malabar plum, which makes uridine diphosphate glucuronic acid a potential biomarker for the consumption of these food products. Uridine diphosphate glucuronic acid can be found primarily in human liver tissue. Uridine diphosphate glucuronic acid exists in all living species, ranging from bacteria to humans. In humans, uridine diphosphate glucuronic acid is involved in several metabolic pathways, some of which include etoposide metabolism pathway, estrone metabolism, tamoxifen action pathway, and androgen and estrogen metabolism. Uridine diphosphate glucuronic acid is also involved in several metabolic disorders, some of which include porphyria variegata (PV), glycogenosis, type III. cori disease, debrancher glycogenosis, 17-beta hydroxysteroid dehydrogenase III deficiency, and hereditary coproporphyria (HCP). Uridine diphosphate glucuronic acid is made from UDP-glucose by UDP-glucose 6-dehydrogenase (EC 1.1.1.22) using NAD+ as a cofactor. It is the source of the glucuronosyl group in glucuronosyltransferase reactions . Uridine diphosphate glucuronic acid is a nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP Iduronic acid, which donates Iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. The transfer of glucuronic acid from UDP-alpha-D-glucuronic acid onto a terminal galactose residue is done by beta1,3-glucuronosyltransferases, responsible for the completion of the protein-glycosaminoglycan linkage region of proteoglycans and of the HNK1 epitope of glycoproteins and glycolipids. In humans the enzyme galactose-beta-1,3-glucuronosyltransferase I completes the synthesis of the common linker region of glycosaminoglycans (GAGs) by transferring glucuronic acid (GlcA) onto the terminal galactose of the glycopeptide primer of proteoglycans. The GAG chains of proteoglycans regulate major biological processes such as cell proliferation and recognition, extracellular matrix deposition, and morphogenesis. (PMID:16815917). Acquisition and generation of the data is financially supported in part by CREST/JST.

   
   

UDP-D-galacturonic acid

(2S,3R,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)


UDP-D-galacturonic acid (UDP-GalA), belongs to the class of organic compounds known as pyrimidine nucleotide sugars. These are pyrimidine nucleotides bound to a saccharide derivative through the terminal phosphate group. UDP-D-galacturonic acid is known to be formed by the 4-epimerization of UDP-D-glucuronic acid. UDP-D-galacturonic acid is an extremely weak basic (essentially neutral) compound (based on its pKa). Outside of the human body, UDP-D-galacturonic acid has been detected, but not quantified in, several different foods, such as peaches, apples, Cucurbita (gourd), agaves, and oats. This could make UDP-D-galacturonic acid a potential biomarker for the consumption of these foods. UDP-D-galacturonate, the activated form of this sugar, is known to be formed by the 4-epimerization of UDP-D-glucuronate. [HMDB]. UDP-D-galacturonate is found in many foods, some of which are japanese persimmon, borage, chives, and caraway.

   

UDP-L-iduronate

(2R,3S,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)


UDP-L-iduronate is converted from UDP-n-glucuronic acid. n-Iduronic and n-glucuronic acid have been identified as the hexuronic acid components of dermatan sulfate. UDP-Dglucose is the metabolic precursor of both uranic acids . Conversion of UDP-u-glucose to UDP-n-glucuronic acid and the subsequent C-5 inversion of UDP-n-glucuronic acid to UDP-Liduronic acid is catalyzed by extracts of mammalian tissues. However, UDP-n-iduronic acid has never been isolated and its role in the polymerization of L-iduronic acid-containing polymers has remained hypothetical. [HMDB] UDP-L-iduronate is converted from UDP-n-glucuronic acid. n-Iduronic and n-glucuronic acid have been identified as the hexuronic acid components of dermatan sulfate. UDP-Dglucose is the metabolic precursor of both uranic acids. Conversion of UDP-u-glucose to UDP-n-glucuronic acid and the subsequent C-5 inversion of UDP-n-glucuronic acid to UDP-Liduronic acid is catalyzed by extracts of mammalian tissues. However, UDP-n-iduronic acid has never been isolated and its role in the polymerization of L-iduronic acid-containing polymers has remained hypothetical.

   

Acid Red 52

Acid Red 52

C27H29N2NaO7S2 (580.1314)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

Epitheaflavic acid 3'-gallate

1-[5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2H-1-benzopyran-2-yl]-3,4,6-trihydroxy-5-oxo-5H-benzo[7]annulene-8-carboxylic acid

C28H20O14 (580.0853)


Epitheaflavic acid 3-gallate is found in tea. Epitheaflavic acid 3-gallate is isolated from black tea Camellia sinensis. Isolated from black tea Camellia sinensis. Epitheaflavic acid 3-gallate is found in tea.

   

Urolithin A 3,8-O-diglucuronide

(2S,3S,4S,5R,6S)-6-[(3-{[(2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy}-6-oxo-6H-benzo[c]chromen-8-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H24O16 (580.1064)


Urolithin A 3,8-O-diglucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

(2R,3R,4R,5S,6R)-6-[[[(2S,3R,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2R,3R,4R,5S,6R)-6-[[[(2S,3R,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)


   

[(2R,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] (3S,4R,5S)-3,4,5,6-tetrahydroxy-2-oxohexanoate

[({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-4-hydroxy-3-[(3,4,5,6-tetrahydroxy-2-oxohexanoyl)oxy]oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C15H22N2O18P2 (580.0343)


   

5,8,13,14-tetraoxa-pentaphene-1,3,6,9,11-pentaol pentaacetate|dioxinodehydroeckol penta-acetate|eckstolonol pentaacetate

5,8,13,14-tetraoxa-pentaphene-1,3,6,9,11-pentaol pentaacetate|dioxinodehydroeckol penta-acetate|eckstolonol pentaacetate

C28H20O14 (580.0853)


   

SCHEMBL12228144

SCHEMBL12228144

C29H24O11S (580.1039)


   
   
   

delphinidin 3-O-(6\'-O-malyl-beta-D-glucoside)

delphinidin 3-O-(6\"-O-malyl-beta-D-glucoside)

C25H24O16 (580.1064)


   

Uridine 5-diphosphoglucuronic acid

Uridine 5-diphosphoglucuronic acid

C15H22N2O18P2 (580.0343)


   

Uridine-5′-diphosphoglucuronic acid trisodium salt

Uridine-5′-diphosphoglucuronic acid trisodium salt

C15H22N2O18P2 (580.0343)


   

Uridine diphosphate glucuronic acid

Uridine diphosphate glucuronic acid

C15H22N2O18P2 (580.0343)


   

Uridine-5-diphosphate glucuronic acid

Uridine-5-diphosphate glucuronic acid

C15H22N2O18P2 (580.0343)


   

URIDINE 5'-DIPHOSPHOGLUCURONIC ACID

URIDINE 5'-DIPHOSPHOGLUCURONIC ACID

C15H22N2O18P2 (580.0343)


   

Epitheaflavic acid 3'-gallate

1-{5,7-dihydroxy-3-[(3,4,5-trihydroxyphenyl)carbonyloxy]-3,4-dihydro-2H-1-benzopyran-2-yl}-3,4,6-trihydroxy-5-oxo-5H-benzo[7]annulene-8-carboxylic acid

C28H20O14 (580.0853)


   

Urolithin A 3,8-O-diglucuronide

(2S,3S,4S,5R,6S)-6-[(3-{[(2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy}-6-oxo-6H-benzo[c]chromen-8-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H24O16 (580.1064)


   

1-BUTANAMINIUM,N,N,N-TRIBUTYL-, (SP-4-1)-BIS[2,3-DI(MERCAPTO-.KAPPA.S)-2-BUTENEDINITRILATO(2-)NICKELATE(1-) (9CI)

1-BUTANAMINIUM,N,N,N-TRIBUTYL-, (SP-4-1)-BIS[2,3-DI(MERCAPTO-.KAPPA.S)-2-BUTENEDINITRILATO(2-)NICKELATE(1-) (9CI)

C24H36N5NiS4 (580.1207)


   

2,2-[[5-acetamido-4-[(2-chloro-4,6-dinitrophenyl)azo]-2-methoxyphenyl]imino]diethyl diacetate

2,2-[[5-acetamido-4-[(2-chloro-4,6-dinitrophenyl)azo]-2-methoxyphenyl]imino]diethyl diacetate

C23H25ClN6O10 (580.1321)


   
   

Tetrabutylammonium Bis(maleonitriledithiolato)nickel(III) Complex

Tetrabutylammonium Bis(maleonitriledithiolato)nickel(III) Complex

C24H36N5NiS4 (580.1207)


   

[(2R,5R)-3-acetyloxy-5-[5-[2-amino-3,5-dicyano-6-(4-fluorophenyl)sulfanylpyridin-4-yl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate

[(2R,5R)-3-acetyloxy-5-[5-[2-amino-3,5-dicyano-6-(4-fluorophenyl)sulfanylpyridin-4-yl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate

C26H21FN6O7S (580.1176)


   

p-Nitrobenzyl (5R,6S)-2-(diphenylphosphoryloxy)-6-((1R)-1-hydroxyethyl)carbapen-2-em-3-carboxylate

p-Nitrobenzyl (5R,6S)-2-(diphenylphosphoryloxy)-6-((1R)-1-hydroxyethyl)carbapen-2-em-3-carboxylate

C28H25N2O10P (580.1247)


   

L-HISTIDINE,N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-1-[(4-METHYLPHENYL)SULFONYL]-

L-HISTIDINE,N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-1-[(4-METHYLPHENYL)SULFONYL]-

C25H20N6O7S2 (580.0835)


   

ER-Tracke Blue-White DPX dye

ER-Tracke Blue-White DPX dye

C26H21F5N4O4S (580.1204)


   

1-[5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyl)oxy-3,4-dihydro-2H-chromen-2-yl]-3,4,6-trihydroxy-5-oxobenzo[7]annulene-8-carboxylic acid

1-[5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyl)oxy-3,4-dihydro-2H-chromen-2-yl]-3,4,6-trihydroxy-5-oxobenzo[7]annulene-8-carboxylic acid

C28H20O14 (580.0853)


   

(2R)-2-hydroxy-4-oxo-4-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-7-oxo-2-(3,4,5-trihydroxyphenyl)chromen-3-yl]oxyoxan-2-yl]methoxy]butanoic acid

(2R)-2-hydroxy-4-oxo-4-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-7-oxo-2-(3,4,5-trihydroxyphenyl)chromen-3-yl]oxyoxan-2-yl]methoxy]butanoic acid

C25H24O16 (580.1064)


   

[(2R,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] (3S,4R,5S)-3,4,5,6-tetrahydroxy-2-oxohexanoate

[(2R,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] (3S,4R,5S)-3,4,5,6-tetrahydroxy-2-oxohexanoate

C15H22N2O18P2 (580.0343)


   

(2S,3S,4S,5R)-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R)-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)


   
   

UDP-alpha-D-mannuronic acid

UDP-alpha-D-mannuronic acid

C15H22N2O18P2 (580.0343)


   

[[(2R,3S,4R,5R)-3,4-dihydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

[[(2R,3S,4R,5R)-3,4-dihydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

C16H26N2O17P2 (580.0707)


   

(2S,3S,4S,5R,6R)-6-[[[(2S,3R,4S,5S)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-6-[[[(2S,3R,4S,5S)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)


   
   

UDP-alpha-D-galacturonic acid

UDP-alpha-D-galacturonic acid

C15H22N2O18P2 (580.0343)


   

UDP-alpha-D-Glucuronic acid

UDP-alpha-D-Glucuronic acid

C15H22N2O18P2 (580.0343)


A UDP-sugar having alpha-D-glucuronic acid as the sugar component.

   

bPiDI

bPiDI

C22H34I2N2 (580.0811)


bPiDI is a novel selective α6β2 nicotinic receptor antagonist. bPiDI inhibits nicotine-evoked striatal dopamine (DA) release through an interaction with α6β2-containing nAChRs[1].

   

EHT 1864

EHT 1864

C25H29Cl2F3N2O4S (580.1177)


EHT 1864 is an inhibitor of Rac family small GTPases. EHT 1864 directly binds and impairs the ability of this small GTPase to engage critical downstream effectors required for growth transformation. The Kd values are 40, 50, 60, and 230 nM for Rac1, Rac1b, Rac2 and Rac3, respectively.?EHT 1864 also potently inhibits other Rac-dependent transformation processes, Tiam1- and Ras-mediated growth transformation. EHT 1864 prevents Aβ?40 and Aβ?42 production in vivo. EHT 1864 dependently suppresses the release of migrasomes from podocytes induced by LPS, PAN, or HG[1][2][3][4].

   

(2s,3r,4s,5r,6r)-6-[({[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3r,4s,5r,6r)-6-[({[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)


   

(2r,3s,4s)-4-(benzylsulfanyl)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

(2r,3s,4s)-4-(benzylsulfanyl)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H24O11S (580.1039)


   

(2s,3s,4s,5r,6r)-6-[({[(2s,3s,4s,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-[({[(2s,3s,4s,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)


   

6,11,12-trihydroxy-4-(4-hydroxybenzoyloxy)-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-yl 4-hydroxybenzoate

6,11,12-trihydroxy-4-(4-hydroxybenzoyloxy)-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-yl 4-hydroxybenzoate

C32H20O11 (580.1006)


   

6-[({[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[({[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)


   

3,7,9,12-tetrakis(acetyloxy)-5,6,11,14-tetraoxapentaphen-1-yl acetate

3,7,9,12-tetrakis(acetyloxy)-5,6,11,14-tetraoxapentaphen-1-yl acetate

C28H20O14 (580.0853)


   

(2s,3s,4s,5r,6r)-6-[({[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-[({[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)


   

(2s,3r,4s,5r,6r)-6-[({[(2r,3r,4s,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3r,4s,5r,6r)-6-[({[(2r,3r,4s,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0343)